Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting.
Conclusion: Our study confirms the real-life efficacy of ranibizumab in DME at M12 and the need for a large number of injections to achieve better visual outcomes. We also showed a trend to a lower compliance in diabetic versus nAMD patients.
PMID: 29850205 [PubMed]
Source: Journal of Ophthalmology - Category: Opthalmology Tags: J Ophthalmol Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Diabetes | Endocrinology | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Study | Vitamin A